Open AccessP1165: BETALUTIN® IN PATIENTS WITH RELAPSED/ REFRACTORY DIFFUSE LARGE B‐CELL LYMPHOMA (DLBCL) NOT ELIGIBLE FOR AUTOLOGOUS STEM CELL TRANSPLANT
Author(s) -
Illidge T.,
Beasley M.,
Codina J. G.,
Cavallo F.,
Pascal V.,
Wills V.
Publication year - 2022
Publication title -
hemasphere
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.677
H-Index - 11
ISSN - 2572-9241
DOI - 10.1097/01.hs9.0000847528.94329.37
Subject(s) - medicine , rituximab , refractory (planetary science) , diffuse large b cell lymphoma , lymphoma , oncology , phases of clinical research , dosing , clinical trial , physics , astrobiology